Page 65 - Tyrosine-Based Bioconjugations - Jorick Bruins
P. 65

(31) J. M. M. Verkade, M. A. Wijdeven, R. van Geel, B. M. G. Janssen, S. S. van Berkel, and Delft, F. L. v., A Polar Sulfamide Spacer Significantly Enhances the Manufacturability, Stability, and Therapeutic Index of Antibody–Drug Conjugates. Antibodies 2018, 7 (12).
(32) Tian, F., Lu, Y. C., Manibusan, A., Sellers, A., Tran, H., Sun, Y., Phuong, T., Barnett, R., Hehli, B., Song, F., et al., A general approach to site-specific antibody drug conjugates. Proc. Natl. Acad. Sci. U. S. A. 2014, 111 (5), 1766-71.
(33) Zimmerman, E. S., Heibeck, T. H., Gill, A., Li, X. F., Murray, C. J., Madlansacay, M. R., Tran, C., Uter, N. T., Yin, G., Rivers, P. J., et al., Production of Site-Specific Antibody-Drug Conjugates Using Optimized Non-Natural Amino Acids in a Cell-Free Expression System. Bioconjugate Chem. 2014, 25 (2), 351-61.
(34) Kim, S., Sung, B. H., Kim, S. C., and Lee, H. S., Genetic incorporation of l- dihydroxyphenylalanine (DOPA) biosynthesized by a tyrosine phenol-lyase. Chem. Commun. 2018, 54 (24), 3002-5.
Dual Protein Labeling via SPOCQ and SPAAC
 63
3




























































































   63   64   65   66   67